These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

811 related items for PubMed ID: 27662315

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Qualitative and Quantitative Analyses of Brain 18Fluoro-Deoxy-Glucose Positron Emission Tomography in Primary Progressive Aphasia.
    Nuvoli S, Tanda G, Stazza ML, Madeddu G, Spanu A.
    Dement Geriatr Cogn Disord; 2019; 48(5-6):250-260. PubMed ID: 32062656
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Memory and emotion processing performance contributes to the diagnosis of non-semantic primary progressive aphasia syndromes.
    Piguet O, Leyton CE, Gleeson LD, Hoon C, Hodges JR.
    J Alzheimers Dis; 2015; 44(2):541-7. PubMed ID: 25298199
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia.
    Ferrari C, Polito C, Berti V, Lombardi G, Lucidi G, Bessi V, Bagnoli S, Piaceri I, Nacmias B, Sorbi S.
    J Alzheimers Dis; 2019; 72(4):1089-1096. PubMed ID: 31683481
    [Abstract] [Full Text] [Related]

  • 11. A disease-specific metabolic imaging marker for diagnosis and progression evaluation of semantic variant primary progressive aphasia.
    Lu J, Huang L, Lv Y, Peng S, Xu Q, Li L, Ge J, Zhang H, Guan Y, Zhao Q, Guo Q, Chen K, Wu P, Ma Y, Zuo C.
    Eur J Neurol; 2021 Sep; 28(9):2927-2939. PubMed ID: 34110063
    [Abstract] [Full Text] [Related]

  • 12. 18F-FDG PET Improves Diagnosis in Patients with Focal-Onset Dementias.
    Taswell C, Villemagne VL, Yates P, Shimada H, Leyton CE, Ballard KJ, Piguet O, Burrell JR, Hodges JR, Rowe CC.
    J Nucl Med; 2015 Oct; 56(10):1547-53. PubMed ID: 26251415
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia.
    Bouwman F, Orini S, Gandolfo F, Altomare D, Festari C, Agosta F, Arbizu J, Drzezga A, Nestor P, Nobili F, Walker Z, Morbelli S, Boccardi M, EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1526-1533. PubMed ID: 29744573
    [Abstract] [Full Text] [Related]

  • 14. Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia.
    Santangelo R, Coppi E, Ferrari L, Bernasconi MP, Pinto P, Passerini G, Comi G, Magnani G.
    J Alzheimers Dis; 2015 Jul; 43(4):1429-40. PubMed ID: 25201781
    [Abstract] [Full Text] [Related]

  • 15. Distinct [18F]THK5351 binding patterns in primary progressive aphasia variants.
    Schaeverbeke J, Evenepoel C, Declercq L, Gabel S, Meersmans K, Bruffaerts R, Adamczuk K, Dries E, Van Bouwel K, Sieben A, Pijnenburg Y, Peeters R, Bormans G, Van Laere K, Koole M, Dupont P, Vandenberghe R.
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2342-2357. PubMed ID: 29946950
    [Abstract] [Full Text] [Related]

  • 16. Clinical course of primary progressive aphasia: clinical and FDG-PET patterns.
    Matias-Guiu JA, Cabrera-Martín MN, Moreno-Ramos T, García-Ramos R, Porta-Etessam J, Carreras JL, Matías-Guiu J.
    J Neurol; 2015 Mar; 262(3):570-7. PubMed ID: 25491078
    [Abstract] [Full Text] [Related]

  • 17. Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns.
    Mazzeo S, Morinelli C, Polito C, Giacomucci G, Moschini V, Ingannato A, Balestrini J, Frigerio D, Emiliani F, Galdo G, Crucitti C, Piazzesi D, Bagnoli S, Padiglioni S, Berti V, Sorbi S, Nacmias B, Bessi V.
    J Neurol Sci; 2024 May 15; 460():122998. PubMed ID: 38615405
    [Abstract] [Full Text] [Related]

  • 18. Comparing Longitudinal Behavior Changes in the Primary Progressive Aphasias.
    Van Langenhove T, Leyton CE, Piguet O, Hodges JR.
    J Alzheimers Dis; 2016 Jun 18; 53(3):1033-42. PubMed ID: 27340847
    [Abstract] [Full Text] [Related]

  • 19. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
    Sajjadi SA, Acosta-Cabronero J, Patterson K, Diaz-de-Grenu LZ, Williams GB, Nestor PJ.
    Brain; 2013 Jul 18; 136(Pt 7):2253-61. PubMed ID: 23729473
    [Abstract] [Full Text] [Related]

  • 20. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C, Della Rosa PA, Magnani G, Santangelo R, Marcone A, Cappa SF, Perani D.
    Neuroimage Clin; 2015 Jul 18; 7():187-94. PubMed ID: 25610780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.